Beretta S, Coppo A, Bianchi E, et al. Neurological outcome of post-anoxic refractory status epilepticus after aggressive treatment. EAN 2018; abstract O425.
Extra voordeel langere dosisinterval natalizumab: minder JCV-conversie
mei 2025 | Multipele Sclerose